Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The closing price of Milestone Pharmaceuticals Inc (NASDAQ: MIST) was $1.81 for the day, down -2.69% from the previous closing price of $1.86. In other words, the price has decreased by -$2.69 from its previous closing price. On the day, 1.74 million shares were traded.
Ratios:
Our analysis of MIST’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 15.40 and its Current Ratio is at 15.40. In the meantime, Its Debt-to-Equity ratio is 2.25 whereas as Long-Term Debt/Eq ratio is at 2.23.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 22, 2024, initiated with a Buy rating and assigned the stock a target price of $9.
On June 20, 2023, Jefferies Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $8 to $4.
Piper Sandler Upgraded its Neutral to Overweight on April 22, 2022, whereas the target price for the stock was revised from $8 to $10.
Stock Price History:
Over the past 52 weeks, MIST has reached a high of $2.75, while it has fallen to a 52-week low of $1.12. The 50-Day Moving Average of the stock is -10.75%, while the 200-Day Moving Average is calculated to be 8.43%.
Shares Statistics:
A total of 53.33M shares are outstanding, with a floating share count of 50.76M. Insiders hold about 4.81% of the company’s shares, while institutions hold 42.47% stake in the company.
